Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Aortic Coarctation

ClinicalTrials.gov lists 48 trials for Aortic Coarctation or a narrower condition beneath it. Renata Medical has the most among industry and government lead sponsors, with 2.

MeSH D001017 Cardiovascular Diseases C14 C16 Listed by Orphanet as a rare disease
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 1 Phase 1 1 Phase 2 Phase 2 1 Phase 3 Phase 3 2 Phase 4 Phase 4 2 Not applicable Not applicable 13 Observational Observational 29 Phase 1 Phase 1 1 Phase 2 Phase 2 1 Phase 3 Phase 3 2 Phase 4 Phase 4 2 Not applicable Not applicable 13 Observational Observational 29

Trials per phase (log scale)

48 of the 48 trials are tagged with Aortic Coarctation itself; the rest are tagged with a narrower condition beneath it.

Get the Aortic Coarctation report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Aortic Coarctation trials start? (18)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 5

2002: 1 trials (Observational 1) 2007: 2 trials (Observational 1, Not applicable 1) 2008: 1 trials (Phase 4 1) 2009: 3 trials (Observational 1, Not applicable 2) 2010: 2 trials (Observational 1, Phase 2 1) 2012: 1 trials (Observational 1) 2013: 3 trials (Observational 3) 2015: 3 trials (Observational 1, Not applicable 2) 2016: 4 trials (Not applicable 3, Phase 1 1) 2017: 1 trials (Observational 1) 2019: 3 trials (Observational 3) 2020: 3 trials (Observational 2, Phase 3 1) 2021: 3 trials (Observational 1, Not applicable 1, Phase 4 1) 2022: 3 trials (Observational 3) 2023: 2 trials (Observational 2) 2024: 4 trials (Observational 1, Not applicable 2, Phase 3 1) 2025: 5 trials (Observational 5)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 3
2025 5
2024 4
2023 2
2022 3
2021 3
2020 3
2019 3
2017 1
2016 4

No forecast is made for this condition: it averages 3.2 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Aortic Coarctation trials in? (6)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 1 1
Phase 2 1
Phase 3 2
Phase 4 2
Not applicable 13
Observational 29

How many Aortic Coarctation trials are recruiting? (7)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Not yet recruiting 5
Recruiting 7
Enrolling by invitation 3
Active, not recruiting 2
Completed 21

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Aortic Coarctation trials? (2)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
Renata Medical 2
Atrium Medical Corporation 1

Which drugs are being tested for Aortic Coarctation? (4)

Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.

Drugs tested
Drug Trials
ATORVASTATIN 1
Levosimendan 1
FENTANYL 1
+/- Bupivacaine HCl 1

Interventions as named in the registry (8)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
Erector Spinae Plane Block 2
Paravertebral Block 1
Serratus anterior plane block (SAP) 1
Maternal Hyperoxygenation 1
Low dose losartan 1

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which serious adverse events do Aortic Coarctation trials report? (2)

Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.

Serious adverse events in this condition's trials
Adverse event Subjects affected Trials
Abnormal exercise echo test at one year 1 1
Aortic Wall Injury 1 1

Which publications cover Aortic Coarctation? (103)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Publications
Publication Journal Year Major topic
Multicenter Pivotal Trial of the Minima Stent for Vascular Stenosis in Infants and Young Children. Circulation. Cardiovascular interventions 2025 Yes
Associations of Home Monitoring Data to Interventional Catheterization for Infants with Recurrent Coarctation of the Aorta and Hypoplastic Left Heart Syndrome. Pediatric cardiology 2023 Yes
Equal cerebral perfusion during extended aortic coarctation repair. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2022 Yes
Long-Term Outcomes of the Coarctation of the Aorta Stent Trials. Circulation. Cardiovascular interventions 2021 Yes
Image-Based Computational Model Predicts Dobutamine-Induced Hemodynamic Changes in Patients With Aortic Coarctation. Circulation. Cardiovascular imaging 2021 Yes

Prevalence (60)

Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.

Prevalence
Orphanet disease Type Class Geography Jurisdiction Mapping relation
Coarctation of aorta Prevalence at birth 1-5 / 10 000 United Kingdom GB Exact
Coarctation of aorta Prevalence at birth 1-5 / 10 000 United Kingdom GB Exact
Coarctation of aorta Prevalence at birth 1-5 / 10 000 United Kingdom GB Unspecified
Coarctation of aorta Prevalence at birth 6-9 / 10 000 Austria Not stated Exact
Coarctation of aorta Point prevalence Unknown Worldwide Not stated Unspecified

Rare-disease identity (2)

Shown in this order: exact, broader, narrower, other.

Rare-disease identity
Orphanet disease ORPHA code Relation Source
Coarctation of aorta 1457 Exact Orphadata Science knowledge files, Product 1
Coarctation of aorta 1457 Exact Orphanet Rare Disease Ontology (ORDO)

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: sub-conditions in mesh.

Browse all condition evidence pages